Alagarasu Kalichamy
Dengue/Chikungunya Group, National Institute of Virology (Indian Council of Medical Research), 20A Dr Ambedkar Road, Pune 411001, Maharashtra, India.
Vaccine. 2016 May 27;34(25):2759-61. doi: 10.1016/j.vaccine.2016.04.070. Epub 2016 May 1.
Diagnosis of dengue virus infections is complicated by preference for different diagnostic tests in different post onset days of illness and the presence of multiple serotypes leading to secondary and tertiary infections. The sensitivity of the most commonly employed diagnostic assays such as anti dengue IgM capture (MAC) ELISA and non structural protein (NS) 1 capture ELISA are lower in secondary and subsequent infections. Introduction of dengue vaccine in endemic regions will affect the way how dengue is diagnosed in vaccinated subjects. This viewpoint article discusses implications of introduction of dengue vaccine on the diagnosis of dengue infections in vaccinated subjects and the strategies that are needed to tackle the issue.
登革病毒感染的诊断较为复杂,这是因为在疾病发作后的不同天数,对不同诊断检测方法存在偏好,并且存在多种血清型会导致二次和三次感染。在二次及后续感染中,最常用的诊断检测方法,如抗登革热 IgM 捕获(MAC)ELISA 和非结构蛋白(NS)1 捕获 ELISA 的灵敏度较低。在流行地区引入登革热疫苗将影响对接种疫苗人群中登革热的诊断方式。这篇观点文章讨论了引入登革热疫苗对接种疫苗人群中登革热感染诊断的影响以及解决该问题所需的策略。